A new scale to measure body awareness and spatial body maps in adults with spinal cord injury
Official title: Development of a Novel Evaluation Scale of Mental Body Representation (MBR) for Adults With Spinal Cord Injury
Run by University of Minnesota · NCT07029802 · Data updated 2026-11-12
This study will test a new questionnaire to measure body awareness and visuospatial body maps in adults with spinal cord injury, including those with and without neuropathic pain.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 80 (estimated) |
| Sponsor | University of Minnesota Academic / other |
| Locations | 1 site (Minneapolis, Minnesota) |
| Status | Recruiting |
| Started | November 18, 2024 |
| Main results expected | June 15, 2027 |
| Study ends | June 15, 2027 |
| Registry record updated | June 18, 2026 |
| Trial ID | NCT07029802 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal participants are adults aged 18 or older with a complete or incomplete spinal cord injury of at least one year who are medically stable, read English, have internet access and can attend an in-person visit at the University of Minnesota, alongside uninjured adult controls aged 18+ for comparison.
✕Probably not a fit
People with uncontrolled seizure disorders, significant cognitive or communication impairments from brain injury, ventilator dependence, major medical complications, or pressure ulcers preventing prolonged sitting or lying are unlikely to be eligible or to benefit from participation.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This cross-sectional observational study will develop and validate a novel Mental Body Representation (MBR) scale tailored for adults with spinal cord injury (SCI). Initial item generation will be done through email and individual interviews conducted remotely via Zoom or in person, followed by psychometric testing. Consenting and baseline questionnaires will occur over Zoom, and participants will complete the new SCI-BodyMap during an in-person visit to examine usability, reliability, and validity. The study includes both adults with chronic SCI (≥1 year) and uninjured adult controls for comparison.
Why it matters
Potential benefit: If successful, the SCI-BodyMap could provide clinicians and researchers a reliable, easy-to-use tool to track body awareness and help tailor rehabilitation or pain management.
How similar studies have gone: Psychometric development using remote interviews followed by in-person testing has been successful for related patient-reported outcome measures, but a dedicated MBR scale specifically for SCI is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: Control group * Uninjured adults (from the contact list with the Brain Body Mind lab or through fliers or StudyFinder) * 18+ years old adults SCI group * 18+ years old, participants with an incomplete or complete SCI of ≥ 1 year * medically stable * able to read and understand English * having access to the internet/iPad/computer/phone and willing to come in for an in-person testing at the University of Minnesota. Exclusion Criteria: SCI group * Uncontrolled seizure disorder; * cognitive impairment and/or communicative disability (e.g., due to brain injury) preventing them from following directions or from learning; * ventilator dependency; * major medical complications; * pressure ulcers hindering prolonged sitting or lying down.
Where it's running
-
University of Minnesota
Minneapolis, Minnesota, United States Recruiting
Study contacts
- Principal investigator: Ann Van de Winckel — University of Minnesota
- Study coordinator: Sydney Carpentier
- Email: carpe749@umn.edu
- Phone: 562-508-9693
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Transcutaneous spinal cord stimulation with 4-aminopyridine and intensive rehab for chronic spinal cord injury
This pilot study tests whether combining noninvasive spinal stimulation, dalfampridine, and rigorous rehab is safe and feasible for adults with chronic spinal cord injury and whether it can help improve movement and walking.
-
NG004 for incomplete cervical spinal cord injury
This trial tests NG004 versus placebo to see if it is safe and helps motor function and daily life in adults with acute incomplete cervical spinal cord injury.
-
Robot-assisted training for arm and leg movement after stroke or injury
This study tests whether adding ZEPU-AI robotic training to usual therapy is safe and helps adults with arm or leg movement problems from stroke, spinal cord injury, brain injury, or orthopedic conditions.
-
ZEPU-AI3 Lower Limb Feedback Training and Evaluation Robot in Rehab
This pilot trial tests whether adding the ZEPU-AI3 robotic leg training with real-time feedback to standard rehab helps adults with lower limb motor problems from stroke, spinal cord injury, or similar conditions.
-
Combined magnetic stimulation and ultrasound for detrusor overactivity in spinal cord injury
This study tests whether using high-frequency sacral nerve stimulation together with bladder-directed ultrasound can reduce involuntary bladder contractions and improve bladder function in people with spinal cord injury.
-
Hybrid HIIT-FES cycling program for people with spinal cord injury
This study tests a hybrid exercise program that combines functional electrical stimulation cycling with voluntary arm work to improve health in adults with spinal cord injury.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.